Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Gaochenxi Zhang"'
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24404- (2024)
Background: Cancer vaccines are an important component of tumour immunotherapy. An increasing number of studies have shown that cancer vaccines have considerable clinical benefits. With the development of tumour precision medicine, cancer vaccines ha
Externí odkaz:
https://doaj.org/article/607b9f33abf046608e2698d001abbbfd
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Immune-related cutaneous adverse events (irCAEs) in patients treated with programmed cell death-1/programmed death-ligand 1 (PD-1/PD-L1) checkpoint inhibitors may be associated with better clinical outcomes. However, the extent to which thes
Externí odkaz:
https://doaj.org/article/369dd85b55284305a280af1d9bab2332
Autor:
Fangmin Zhao, Rui Yu, Shuyi Chen, Shuya Zhao, Lin Sun, Zeting Xu, Yao Zhang, Shuying Dai, Gaochenxi Zhang, Qijin Shu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPrecision cancer medicine-related rashes are a kind of skin and mucous lesions caused by precision therapy. More and more evidences indicated that such events should not be ignored in the course of anti-tumor therapy. Since cancer treatment
Externí odkaz:
https://doaj.org/article/8da7123bfdaf41969e325f7c0301b853
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Background. Lung cancer has a poor prognosis and a high mortality rate, and patients may develop multidrug resistance. Sparganii Rhizoma-Curcumae Rhizoma (HCSC), the classic herbal drug combination of traditional Chinese medicine (TCM), is commonly u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695b217169cf71e590adb9ebbf4f5dda
https://doi.org/10.1155/2021/6664489
https://doi.org/10.1155/2021/6664489
Publikováno v:
Pharmaceutical Biology, Vol 59, Iss 1, Pp 1294-1304 (2021)
Pharmaceutical Biology
article-version (VoR) Version of Record
Pharmaceutical Biology
article-version (VoR) Version of Record
Context Yang-Yin-Jie-Du Decoction (YYJDD) was used to improve gefitinib efficacy in our clinical practice, but its mechanism remains unclear. Objective This study explored if YYJDD could reverse gefitinib resistance. Materials and methods H1975 cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c27c513bc0e732335205640510e128
https://doi.org/10.1080/13880209.2021.1972122
https://doi.org/10.1080/13880209.2021.1972122
Objective To systematically review the cohort studies about the relation between immune-related Cutaneous Adverse Events(irCAEs) and clinical benefit in patients treated with Programmed Cell Death Protein-1(PD-1)/Programmed Death-Ligand 1(PD-L1) inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2d2787420ee6d81f5a81999339f26a8
https://doi.org/10.21203/rs.3.rs-1601395/v1
https://doi.org/10.21203/rs.3.rs-1601395/v1
Autor:
Haibing Wang, Gaochenxi Zhang
Publikováno v:
Biochemical and Biophysical Research Communications. 517:477-483
β,β-Dimethylacrylshikonin (DMAS), an active ingredient of Lithospermum erythrorhizon and Arnebia euchroma, possess anti-neoplasm properties. Recently, DMAS was reported to stimulate autophagy in lung adenocarcinoma cells. However, the mechanisms by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fb2a1a991253f54e1649807cb31431a
https://doi.org/10.1016/j.bbrc.2019.07.100
https://doi.org/10.1016/j.bbrc.2019.07.100
Autor:
Haibin Wang, Ting Chen, Gaochenxi Zhang, Shuying Dai, Yiyi Chen, Chen Shuyi, Xiaolu Cai, Qijin Shu, Shou Liumei
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 138, Iss, Pp 111506-(2021)
Taxus chinensis var. mairei (TC) is a traditional Chinese ornamental and medicinal plant, the leaves and twigs of which are used in anti-tumor therapy in southern China. However, the mechanism and role of aqueous extract of TC (AETC) in promoting apo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52626832ae68b80575997108b7b2a302
http://www.sciencedirect.com/science/article/pii/S0753332221002912
http://www.sciencedirect.com/science/article/pii/S0753332221002912
Autor:
Fangmin Zhao, Rui Yu, Shuyi Chen, Shuya Zhao, Lin Sun, Zeting Xu, Yao Zhang, Shuying Dai, Gaochenxi Zhang, Qijin Shu
Publikováno v:
Frontiers in Immunology; 8/26/2022, Vol. 13, p1-17, 17p
Autor:
Wang Hong, Zaiwei Huang, Liang Yi, Chen Huihui, Ying Wang, Gaochenxi Zhang, Wenpei Zhu, Kayembe Mwimbi David, Mwema Ngoy Gracia, Shuyi Chen, Qijin Shu, Dan Wang
Publikováno v:
International Journal of Clinical Oncology and Cancer Research. 6:74
Management of non-small cell lung cancer has been changed dramatically since detection of EGFR mutation. The rate of EGFR mutation in East China is unknown. In China, lung cancer is the most frequently diagnosed cancer and the leading cause of cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::552cd6477b132e780e70c7eb2173c0e1
https://doi.org/10.11648/j.ijcocr.20210602.14
https://doi.org/10.11648/j.ijcocr.20210602.14